Life insurer Brighthouse Financial's Q2 adjusted EPS misses estimates

Reuters
Aug 08
Life insurer Brighthouse Financial's <a href="https://laohu8.com/S/QTWO">Q2</a> adjusted EPS misses estimates

Overview

  • Brighthouse Q2 adjusted EPS of $3.43 misses analyst expectations, per LSEG data

  • Net income rises to $60 mln from $9 mln in Q2 2024

  • Company repurchased $102 mln of common stock year-to-date

Outlook

  • Company anticipates volatility in net income due to market performance impacts

Result Drivers

  • ANNUITY SALES - Driven by an 8% quarter-over-quarter and 16% sequential increase, primarily in fixed annuities, while Shield Level Annuities remained flat

  • LIFE SALES - Increased 18% quarter-over-quarter but decreased 8% sequentially, driven by Brighthouse SmartCare

  • CAPITAL POSITION - Maintained a strong estimated combined RBC ratio of 405%-425% and holding company liquid assets of $0.9 bln

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Adjusted EPS

Miss

$3.43

$4.46 (8 Analysts)

Q2 EPS

$1.02

Q2 Adjusted Net Income

Miss

$198 mln

$263.20 mln (6 Analysts)

Q2 Net Income

$60 mln

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 6 "hold" and 2 "sell" or "strong sell"

  • The average consensus recommendation for the multiline insurance & brokers peer group is "buy."

  • Wall Street's median 12-month price target for Brighthouse Financial Inc is $56.00, about 15.2% above its August 6 closing price of $47.48

  • The stock recently traded at 2 times the next 12-month earnings vs. a P/E of 3 three months ago

Press Release: ID:nBw4VpLZ3a

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10